[Korea goyounghun financial newspaper reporter] funds of 678.3 billion won rushed to the general public offer of in vitro diagnostics company specializing in mass spectrometry ahseuta.
Ahseuta posted a competitive offer for 484.52 1-1 subscribed public offering conducted in the last 9 to 10 the public. 175 cases were received in 8844 the total IPO IPO shares allotted to retail investors in Manchuria 35 million.
Ahseuta gotta founded in 2006, it is a core product, Saratov MALDI mass spectrometry-based microbial identification and in vitro diagnostic device company. In recognition of the technology to the current state deficit it has passed the preliminary examination gisulseong exception of the Korea Exchange. It is scheduled to be listed on the KOSDAQ 20 days after 14 days of margin payment.
Financial Daily Economic News FNTIMES - unauthorized reproduction for commercial purposes in accordance with the Copyright Act, No copying, distribution,
Copyright ⓒ Korea's financial newspaper & FNTIMES.com
Saturday, March 11, 2017
Ahseuta, IPO subscribed 1 485 competition ... 678.3 billion won flock
